The Lancet

Effective cataract surgical coverage in adults aged 50 years and older: empirical estimates from population-based surveys in 68 countries and modelled estimates for 2000–30

aInternational Centre for Eye Health, London School of Hygiene & Tropical Medicine, London, UK bDepartment of Infectious Disease Epidemiology and International Health, Faculty of Epidemiology and ...

Alcon spends up to $200m to co-develop customisable cataract lenses with RxSight

The companies will combine their expertise to develop a ‘tuneable’ presbyopia-correcting intraocular lens (PCIOL) for ...

RxSight, Inc. Announces Preliminary Second Quarter Financial Results and Product Pipeline Updates Following Strategic Collaboration Agreement

RxSight, Inc. (NASDAQ: RXST) today announced select preliminary financial results for the second quarter of 2026 and updates to its standalone product pipeline, following the announcement of the ...

Lafayette woman first in LA to get new cataract implant

A new artificial lens implant for cataract treatment, the FineVision HP, has received approval from the Food and Drug Administration for use in the United States.